The FDA announced on Oct. 8, 2020, that RaySearch Laboratories AB voluntarily recalled its RayStation standalone software treatment planning system due to potential incorrect linking of regions of interest. This Class II recall affects 2,768 units distributed nationwide.
How to tell if you have it
- Brand: RaySearch
- Product: RayStation standalone software treatment planning system
- Model Numbers: 4.0, 4.5, 4.7, 4.9, 5.0, 6.0, 6.1, 6.2, 6.3, 7.0, 8.0, 8.1, 9.0, 9.1, 9.2, 10.0
- Software Versions: 4.0.0.14, 4.0.3.4, 4.5.1.14, 4.7.2.5, 4.7.3.13, 4.7.4.4, 4.7.5.4, 4.7.6.7, 4.9.0.42, 5.0.1.11, 5.0.2.35, 5.0.3.17, 6.0.0.24, 6.1.1.2, 6.2.0.7, 6.3.0.6, 7.0.0.19, 8.0.0.61, 8.0.1.10, 8.1.0.47, 8.1.1.8, 8.1.2.5, 9.0.0.113, 9.1.0.933, 9.2.0.483, 10.0.0.1154
- Units Affected: 2768
The hazard
According to the FDA, if a region of interest (ROI) or point of interest (POI) referenced from an imported plan is missing in the imported RT Structure Set, the reference may become linked to the wrong ROI or POI.
Context
GovInfoNow's records show RaySearch Laboratories AB has issued 36 other recalls since July 17, 2017. Other recent recalls of similar products include Elekta Leksell GammaPlan software version 11.3/11.4 recall (Dec. 12, 2025) and Hitachi Proton Beam Therapy System Recall (Feb. 6, 2026).